Transcatheter mitral valve repair with the PASCAL device showed high rates of survival and freedom from heart failure rehospitalization at 2 years in the single-arm, safety and efficacy CLASP study.

SAN FRANCISCO, Oct. 26, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two ...

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences Corporation (EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...

TCT 1857: Successful Coil Embolization of a Large Coronary Pseudoaneurysm After Repeated Drug‑Coated Balloon Angioplasty: A Complex Case Report Receive the the latest news, research, and presentations ...

Evoque Tricuspid Replacement in Patient With Multiple Leads Using Intracardiac Echocardiography Alone With the "Back-Bend" Technique Receive the the latest news, research, and presentations from major ...

Edwards’ financials reveal that its transcatheter mitral and tricuspid therapies (TMTT) portfolio grew by 56.4% in 2025.

The mitral valve allows blood to flow from the left atrium of the heart into the left ventricle. Mitral regurgitation occurs when the mitral valve leaks blood back into the left atrium. A person’s ...

Mitral valve regurgitation is a heart condition that occurs when the mitral valve does not close properly, allowing blood to flow backward into the left atrium. Symptoms do not always occur. When they ...